Javascript must be enabled to continue!
Studies on Computational Molecular Interaction Between SARS-CoV-2 Main Protease and Natural Products
View through CrossRef
A combination of docking
approaches, scoring functions, molecular dynamic simulation, and literature
mining have been employed to screen readily available natural products (unique
27256 chemical entities, 598435 unique compounds), which can inhibit the
SARS-CoV-2 main protease. Theaflavin digallate, a major constituent of black
tea, has been observed to be as three top hits after the virtual screening of
598435 unique compounds. The main protease-theaflavin digallate complex
appeared to be in the metastable stage and interact with critical active site
residues of the main protease during molecular dynamics simulation for 200 ns.
Invitro
evidence on main protease
inhibition of 2003 SARS-CoV by theaflavin digallate is available in the
scientific literature. As evident by the dynamics of intermolecular
interactions, theaflavin digallate, forms approximately three hydrogen bonds
with Glu166 of main protease, mostly through hydroxyl groups in the benzene
ring of benzo(7) annulen-6-one. Glu166 is the most critical amino acid for main
protease dimerization, which in turn, is necessary for catalytic activity.
We have employed chloroquine and epigallocatechin
gallate (green tea component) as a control set. Based on computational
molecular interaction and data available in scientific literature, theaflavin
digallate can inhibit the main protease of SARS-CoV-2.
Title: Studies on Computational Molecular Interaction Between SARS-CoV-2 Main Protease and Natural Products
Description:
A combination of docking
approaches, scoring functions, molecular dynamic simulation, and literature
mining have been employed to screen readily available natural products (unique
27256 chemical entities, 598435 unique compounds), which can inhibit the
SARS-CoV-2 main protease.
Theaflavin digallate, a major constituent of black
tea, has been observed to be as three top hits after the virtual screening of
598435 unique compounds.
The main protease-theaflavin digallate complex
appeared to be in the metastable stage and interact with critical active site
residues of the main protease during molecular dynamics simulation for 200 ns.
Invitro
evidence on main protease
inhibition of 2003 SARS-CoV by theaflavin digallate is available in the
scientific literature.
As evident by the dynamics of intermolecular
interactions, theaflavin digallate, forms approximately three hydrogen bonds
with Glu166 of main protease, mostly through hydroxyl groups in the benzene
ring of benzo(7) annulen-6-one.
Glu166 is the most critical amino acid for main
protease dimerization, which in turn, is necessary for catalytic activity.
We have employed chloroquine and epigallocatechin
gallate (green tea component) as a control set.
Based on computational
molecular interaction and data available in scientific literature, theaflavin
digallate can inhibit the main protease of SARS-CoV-2.
Related Results
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus , is causing a serious worldwide COVID-19 pandemic. The emergence of strains with rapid spread and...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology tests
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology tests
Abstract
Background
SARS-CoV-2 serology tests are clinically useful to document a prior SARS-CoV-2 infection in patients with n...
Mutations in SARS-CoV
Mutations in SARS-CoV
The coronavirus family is named for the large spike protein molecules found
on the pathogen exterior, which give the virus a crown-like appearance, the coronavirus
genome is the bi...
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
AbstractBackgroundSevere acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to...
Transmisi Vertikal SARS-CoV-2: Kajian Pustaka
Transmisi Vertikal SARS-CoV-2: Kajian Pustaka
Abstract. COVID-19 is a health problem that originated in Wuhan, China, and spread throughout the world causing the COVID-19 pandemic. The disease caused by SARS-CoV-2 spreads quic...
Coronavirus infections in monocytes and macrophages
Coronavirus infections in monocytes and macrophages
Severe cases of SARS-CoV-2, the causative agent of COVID-19, are often accompanied by dysregulated immune responses. Monocytes and Macrophages, which are part of the innate immune ...
Modeling Coronavirus Spike Protein Dynamics: Implications for Immunogenicity and Immune Escape
Modeling Coronavirus Spike Protein Dynamics: Implications for Immunogenicity and Immune Escape
ABSTRACT
The ongoing COVID-19 pandemic is a global public health emergency requiring urgent development of efficacious vaccines. While concentrated research efforts...

